Abstract
A germline WT-1 point mutation is described in a patient with unilateral Wilms' tumor, nephritis and ambiguous external genitalia. The patient was diagnosed as a possible case of Denys Drash syndrome (DDS). Analysis of the WT-1 exons and intron borders revealed a G to C transversion in the +1 position of the splice donor consensus sequence in intron 6. Two transcripts of abnormal size were identified in tumor RNA. Sequencing of the altered WT-1 mRNA revealed that this point mutation leads to exon-skipping, resulting in transcripts either missing exon 6 or exons 5 and 6. The normally occurring alternative splicing of exon 5 in the WT-1 gene is not affected by this mutation. The reading frame is changed when either both exons 5 and 6 or exon 6 alone are missing and a stop codon follows immediately downstream in exon 7. Most mutations identified in DDS are missense mutations located in the zinc finger (ZF) region (exons 7, 8 and 9) but recently a patient with a germline mutation in exon 6 leading to premature chain termination was described. Therefore the site of the mutation in the WT-1 gene in this patient cannot exclude the possibility that he has DDS.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baird PN, Santos A, Groves N, Jadresic L, Cowell JK (1992) Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome. Hum Mol Genet 1:301–305
Bickmore WA, Oghene K, Little MH, Seawright A, Van Heyningen V, Hastie ND (1992) Modulation of DNA binding specifity by alternative splicing of the Wilms tumor wt1 gene transcript. Science 257:235–237
Brenner B, Wildhardt G, Schneider S, Royer-Pokora B (1992) RNA polymerase chain reaction detects different levels of four alternatively spliced WT1 transcripts in Wilms' tumors. Oncogene 7:1431–1433
Bruening W, Bardeesy N, Silverman BL, Cohn RA, Machin GA, Aronson AJ, Housman D, Pelletier J (1992) Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development. Nature Genet 1:144–148
Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509–520
Compton DA, Weil MM, Bonetta L, Huang A, Jones C, Yeger H, Williams BRG, Strong LC, Saunders GF (1990) Definition of the limits of the Wilms' tumor locus on human chromosome 11p13. Genomics 6:309–315
Cowell JK, Wadey RB, Haber DA, Call KM, Housman DE, Pritchard-Jones K (1991) Structural rearrangements of the WT1 gene in Wilms' tumour cells. Oncogene 6:595–599
Denys P, Malvaux P, Van den Berghe H, Tanghe W, Procsmans W (1967) Association d'une tumor de Wilms, d'une nephropathie parenchymateuse et d'un mosaicisne XX/XY. Arch Fr Pediatr 24:729–739
Drash A, Sherman F, Hartmann WH, Blizzard RM (1970) A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension and degenerative renal disease. J Pediatr 76:585–593
Eubanks JH, Selleri L, Hart R, Rosette C, Evans GA (1991) Isolation, localization, and physical mapping of a highly polymorphic locus on human chromosome 11q13. Genomics 11:720–729
Garey JR, Harrison LM, Franklin KF, Metcalf KM, Radisky ES, Kushner JP (1990) Uroporphyrinogen decarboxylase: a splice site mutation causes the deletion of exon 6 in multiple families with porphyria cutanea tarda. J Clin Invest 86:1416–1422
Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GAP (1990) Homozygous deletion in Wilms' tumour of a zinc-finger gene identified by chromosome jumping. Nature 343:774–778
Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, Douglass EC, Housman DE (1990) An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell 61:1257–1269
Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE (1991) Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA 88:9618–9622
Habib R, Loirat C, Gubler MC (1985) The nephropathy associated with male pseudohermaphroditism and Wilms' tumour (Drash syndrome): a distinctive glomerular lesion report of 10 cases. Clin Nephrol 24:269–278
Huff V, Miwa H, Haber DA, Call KM, Housman D, Strong LC, Saunders GF (1991) Evidence for WT1 as a Wilms' tumor gene: Intragenic germinal deletion in bilateral WT. Am J Hum Genet 48:997–1003
Jadresic L, Leake J, Gordon I, Dillon MJ, Grant DB, Pritchard J, Risdon RA, Barratt TM (1990) Clinicopathologic review of twelve children with nephropathy, Wilms tumor and genital abnormalities (Drash syndrome). J Pediatr 117:717–725
Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, Breg WR, Jones Jr HW, Rary JM (1977) Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 74:1245–1249
Little MH, Prosser J, Condie A, Smith PJ, Van Heyningen V, Hastie ND (1992) Zinc finger point mutations within the WT1 gene in Wilms tumor patients. Proc Natl Acad Sci USA 89:4791–4795
Madden SL, Cook DM, Morris JF, Gashler A, Sukhatme VP, Rauscher FJ III (1991) Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science 253:1550–1553
Mitchell PJ, Urlab G, Chasin L (1986) Spontaneous splicing mutations at the dihydrofolate reductase locus in Chinese hamster ovary cells. Mol Cell Biol 6:1926–1935
Ohno K, Suzuki K (1988) A splicing defect due to an exon-intron junctional mutation results in abnormals β-hexosaminidase α-chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs disease. Biochem Biophys Res Commun 153:463–469
Parkinson DB, Thakker RV (1992) A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism. Nature Genet 1:149–152
Pelletier J, Bruening W, Li FP, Haber GA, Glaser T, Housman DE (1991a) WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour. Nature 353:431–434
Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman D (1991b) Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash Syndrome. Cell 67:437–447
Pritchard-Jones K, Fleming S (1991) Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications or tumour histogenesis. Oncogene 6:2211–2220
Rauscher FJ, Morris JF, Tournay OE, Cook DM, Curran T (1990) Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 250:1259–1262
Royer-Pokora B, Schneider S (1992) Wilms' tumor-specific methylation pattern in 11p13 detected by PFGE. Genes, Chromosomes Cancer 5:132–140
Royer-Pokora B, Ragg S, Heckl-Östereicher B, Held M, Loos U, Call K, Glaser T, Housman D, Saunders G, Zabel B, Williams B, Poustka A (1991) Direct pulsed field gel electrophoresis of Wilms' tumors shows that DNA deletions in 11p13 are rare. Genes, Chromosomes Cancer 3:89–100
Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463–5467
Tadokoro K, Fujii H, Ohshima A, Kakizawa Y, Shimizu K, Sakai A, Sumiyoshi K, Inoue T, Hayashi Y, Yamada M (1992) Intragenic homozygous deletion of the WT1 gene in Wilms' tumor. Oncogene 7:1215–1221
Ton CCT, Huff V, Call KM, Cohn S, Strong LC, Housman DE, Sauders GF (1991) Smallest region of overlap in Wilms tumor deletions uniquely implicates an 11p13 zinc finger gene as the disease locus. Genomics 10:293–297
Visvader J, Begley CG (1991) Helix-loop-helix genes translocated in lymphoid leukemia. Trends Biochem Sci 16:330–333
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schneider, S., Wildhardt, G., Ludwig, R. et al. Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms' tumor and severe genital malformations. Hum Genet 91, 599–604 (1993). https://doi.org/10.1007/BF00205087
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00205087